Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-119631
Filing Date
2014-03-28
Accepted
2014-03-28 06:11:09
Documents
15
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d696371d10k.htm 10-K 1448508
2 EX-23.1 d696371dex231.htm EX-23.1 1412
3 EX-31.1 d696371dex311.htm EX-31.1 6122
4 EX-31.2 d696371dex312.htm EX-31.2 6089
5 EX-32.1 d696371dex321.htm EX-32.1 3543
6 EX-32.2 d696371dex322.htm EX-32.2 3238
7 GRAPHIC g696371tx_pg007.jpg GRAPHIC 19435
8 GRAPHIC g696371tx_pg008.jpg GRAPHIC 46694
9 GRAPHIC g696371tx_pg009.jpg GRAPHIC 36549
10 GRAPHIC g696371tx_pg010.jpg GRAPHIC 44571
11 GRAPHIC g696371tx_pg011.jpg GRAPHIC 17355
12 GRAPHIC g696371tx_pg012a.jpg GRAPHIC 59480
13 GRAPHIC g696371tx_pg012b.jpg GRAPHIC 14910
14 GRAPHIC g696371tx_pg013.jpg GRAPHIC 81101
15 GRAPHIC g696371tx_pg014.jpg GRAPHIC 27250
  Complete submission text file 0001193125-14-119631.txt   1949903
Mailing Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037
Business Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037 (858) 558-2400
Auspex Pharmaceuticals, Inc. (Filer) CIK: 0001454189 (see all company filings)

EIN.: 954862842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36292 | Film No.: 14723184
SIC: 2834 Pharmaceutical Preparations